PIQLF (Proteomics International Laboratories) Additional Paid-In Capital: $0.00 Mil(As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

PIQLF Proteomics International Laboratories Ltd PIQLF
32 GF Score
Price $0.26
GF Value $0.81
! 3 Warning Signs
View Full Analysis

What is Proteomics International Laboratories Additional Paid-In Capital?

Proteomics International Laboratories PIQLF -16.13% 32 Additional Paid-In Capital is $0.00 Mil as of Dec. 2025. GuruFocus rates PIQLF with a GF Score™ of 32/100 and a GF Value™ of $0.81. The stock has 3 warning signs investors should review.


Proteomics International Laboratories Additional Paid-In Capital Related Terms

Proteomics International Laboratories Additional Paid-In Capital Historical Data

* Premium members only.

The historical data trend for Proteomics International Laboratories's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Proteomics International Laboratories Additional Paid-In Capital Chart

Proteomics International Laboratories Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Proteomics International Laboratories Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
PIQLF
32GF Score
Proteomics International Laboratories Ltd PIQLF
Additional Paid-In Capital is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Proteomics International Laboratories Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)
What does a Additional Paid-In Capital of $0.00 Mil mean?
Proteomics International Laboratories (PIQLF) has a Additional Paid-In Capital of $0.00 Mil as of Dec. 2025. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Proteomics International Laboratories and its competitors.
Is Proteomics International Laboratories' Additional Paid-In Capital too high?
Proteomics International Laboratories' current Additional Paid-In Capital is $0.00 Mil. Overall, Proteomics International Laboratories has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Proteomics International Laboratories' Additional Paid-In Capital compare to VRTX and REGN?
Proteomics International Laboratories' Additional Paid-In Capital of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Additional Paid-In Capital for a Biotechnology company?
A good Additional Paid-In Capital depends on the Biotechnology industry context. However, Additional Paid-In Capital should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Additional Paid-In Capital mean?
A high Additional Paid-In Capital can signal that a stock is expensive relative to its fundamentals. Additional paid-in capital is the capital a company raises in excess of par value. View historical data on Proteomics International Laboratories and its competitors. Proteomics International Laboratories's current Additional Paid-In Capital is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Proteomics International Laboratories stock overvalued right now?
Proteomics International Laboratories (PIQLF) has a current Additional Paid-In Capital of $0.00 Mil. The stock's GF Value™ is $0.81, compared to a current price of $0.26 — trading 67.9% below its estimated fair value. The current Additional Paid-In Capital is $0.00 Mil. Proteomics International Laboratories' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Additional Paid-In Capital calculated?
Additional Paid-In Capital is calculated from a company's financial statements. For Proteomics International Laboratories (PIQLF), the current Additional Paid-In Capital is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Proteomics International Laboratories (PIQLF) Overvalued in 2026?

Based on GuruFocus' analysis, Proteomics International Laboratories stock appears to be undervalued. The current stock price of $0.26 is trading 67.9% below its estimated GF Value™ of $0.81.

Key valuation signals for PIQLF:

  • Additional Paid-In Capital: $0.00 Mil
  • GF Value™: $0.81 vs. price of $0.26 (67.9% below fair value)
  • GF Score™: 32/100 with 3 warning signs

No single metric tells the full story. See the PIQLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Proteomics International Laboratories Business Description

Other Exchanges PIQ:Australia
Address 6 Verdun Street, QEII Medical Centre, QQ Block, Nedlands, Perth, WA, AUS, 6009
Proteomics International Laboratories Ltd is a biological research and drug discovery company. It is a pioneering medical technology company operating at the forefront of predictive diagnostics and precision medicine. The Company specialises in proteomics-the industrial-scale study of the structure and function of proteins. Its pipeline includes Promarker, Pipeline PromarkerD, PromarkerEndo, PromarkerEso, and OxiDx.
32GF Score

Get the complete analysis for PIQLF

Additional Paid-In Capital is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.26
Price
$0.81
GF Value